Skip to content

Public FDA record

Z-0459-2008: Roche Diagnostics LightCycler Capillaries (100uL) for use in conjunction with the LightCycler analyzers;

Recall record Z-0459-2008 for Roche Diagnostics Corp.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0459-2008
Company in FDA record
Roche Diagnostics Corp.
FDA classification date
Dec 12, 2007
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

False Negative Results: Air bubbles in the lens or the area surrounding the lens of the LightCycler 100 uL capillaries may cause false negative results. The affected capillaries showed up to a 40% reduction in signal

Source facts

Action
Consignees were notified by Urgent Medical Device Recall letter dated 8/30/07, to discontinue use of the 100uL capillaries, plus all of those received at installation, and to disposed of them per local guidelines.
Initiated
2007-08-30
Root cause
Process design
Terminated
2008-09-08
Distribution
Nationwide
Recall number
Z-0459-2008
Recall status
Terminated
CDRH record ID
54521
FDA classified
2007-12-12
Recall event number
38897

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗